Skip to main content

Search
Neonatology

Research Funding

|

Research Funding

Grant TitleGrantorAmountAward Date
Sandra E. Juul, MD, PhDBiomarkers of brain injury and inflammation in perinatal hypoxic ischaemic encephalopathy.Innovative Research Grant, CP Alliance. $120,000Jan. 2, 2014 - Jan. 1, 2015
Christopher M. Traudt, MDMechanisms of cerebellar injury after posterior fossa hemorrhage.Pediatrics Endowed Professorship for Research Faculty Development $, $125,000Oct. 1, 2013 - Sept. 30, 2016
Sandra E. Juul, MD, PhDNeonatal Erythropoietin and Therapeutic Hypothermia Outcomes Study (NEAT O).Thrasher FoundationSept. 1, 2013 - Aug. 30, 2015
Sandra E. Juul, MD, PhDPreterm Erythropoietin Neuroprotection Trial (PENUT Trial) CCC.NINDS 1U01NS077953-01 $10,255,370July 1, 2013 - June 30, 2018
Sandra E. Juul, MD, PhDBiomarkers of neonatal encephalopathy in a nonhuman primate model.NICHD 1 R01 HD073128-01A1 $2,496,627July 1, 2013 - June 30, 2018
Dennis E. Mayock, MDNeonatal Erythropoietin and Therapeutic Hypothermia Short-Term Outcome Study (NEAT O Study).Trasher Foundation $, $7,869 2013 - 2016
Dennis E. Mayock, MDPreterm Erythropoietin Neuroprotection Trial (PENUT Trial) NINDS 1U01NS077953-01 $10,255,370 2013 - 2018
Dennis E. Mayock, MDNeonatal CMV infection: a comparative effectiveness study of transfusion safetyDepartment of Pediatrics AEF 2013 - 2015
Taylor Lee Sawyer, DO, M.EdInterprofessional Education Collaborative collection in AAMCs MedEdPORTALAssociation of American Medical Colleges $2,000 2013
Taylor Lee Sawyer, DO, M.EdVideo-Laryngoscopy versus Direct Laryngoscopy for Neonatal Intubation: A RandomizedUW Neonatal Bioresearch Fund $6,000 2013
Ryan M. McAdams, MD"Is prolonged exposure to dexmedetomidine safe for neonates?"Seattle Children's Hospital Center for Clinical and Translational Research Grant, Seattle, WA $20000Sept. 28, 2012 - Sept. 28, 2013
Ryan M. McAdams, MD"GBS mediated in utero fetal injury"NIH $$620,956July 1, 2012 - June 30, 2017
Ryan M. McAdams, MD"GBS mediated in utero fetal injury"NIH $620,956July 1, 2012 - June 30, 2017
Sandra E. Juul, MD, PhDDANCE trial. Darbepoietin Administration in Newborns Undergoing Cooling for EncephalopathyThrasher Grant $45,252 2012 - 2014
Dennis E. Mayock, MDDarbe Administration in Newborns Undergoing Cooling for Encephalopathy (DANCE Trial)Trasher Grant $, $41,994 2012 - 2014
Christopher M. Traudt, MDCerebellar Development Disruption After Perinatal Brain InjuryK12 CHRC Scholar Development Award, Child Health Research Center subcontract, NIH NICHD $, $170,000Jan. 1, 2012 - Dec. 31, 2014
Ryan M. McAdams, MD"Are the neurodevelopmental effects of neonatal stress and morphine regulated by miRNAs?" $25,000Sept. 1, 2010 - Oct. 1, 2013
Sandra E. Juul, MD, PhDA Novel Non-Human Primate Model of Neonatal Stress and Sedative Drug Use.Institute of Translational Health Sciences $67500 2010 - 2012
Dennis E. Mayock, MDPhase I Multicenter Clinical Trial of Early High-Dose Erythropoietin in Term Infants with Hypoxic-Ischemic Encephalopathy (NEAT Trial)Thrasher Foundation 2010 - 2013
Dennis E. Mayock, MDGene Targets for IVHNINDS 2010 - 2012
Dennis E. Mayock, MDU01 (Subcontract to Ballard); NHLBI; Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia (BPD): The TOLSURF Study $, $155,042Sept. 15, 2009 - July 31, 2014
Sandra E. Juul, MD, PhDARRA supplement to R01-HD-52820-01A3NICHD $204100 2009 - 2012
Ryan M. McAdams, MDOptimizing neuroprotection following perinatal asphyxia"NIH/NICHD $2,196,613Sept. 17, 2007 - June 30, 2012
Christopher M. Traudt, MDOptimizing neuroprotection following perinatal asphyxiaNIH NICHD R01-HD-52820-01A2 June 1, 2007 - May 31, 2013
Kendra M. Smith, MDPartial liquid ventilation for lung protection in congenital diaphragmatic hernia (CDH) patients on ECLSSeattle Childrens Hospital -Academic Enrichment Fund $50,000
Kendra M. Smith, MDA multi-center, randomized, placebo-controlled, double-blind, two-armed, parallel group study to evaluate efficacy and safety of IV Sildenafil in the treatment of neonates with persistent pulmonary hypertension of the newborn or hypoxic respiratory failure and at risk for persistent pulmonary hypertension, with a long term follow-up investigation of developmental progress 12 and 24 months after completion of study treatment.Pfizer Pharmaceutical Company $51,827
Academic Annual Report